#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18194	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2291	964.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1558	1558	C	1096	C,T	1094,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18194	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2291	964.5	0	HET	.	.	.	G1158A,C,T	.	1158	1158	G	1532	1532	G	1096	G,A,C,T	822,271,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29996	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	902.0	0	.	n	.	0	T695C	SNP	695	695	T	1370	1370	C	1163	C,A,T	1157,4,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29996	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	902.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	2012	2012	A	1235	A,C	1231,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29996	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	902.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2646	2646	C	1058	C,A	1057,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29996	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	902.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3272	3272	T	1001	T,C,A,G	754,245,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29996	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	902.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2720	2720	A	968	A,G	967,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29996	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	902.0	0	HET	.	.	.	G2872A,T,C	.	2872	2872	G	3547	3547	G	1078	G,A,T,C	581,495,1,1	.	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2694	folP	852	852	100.0	folP.l15.c4.ctg.1	2112	159.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1310	1312	AGC	269;269;269	A;G;C,G	269;269;268,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6418	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3800	210.6	1	SNP	p	S91F	0	.	.	271	273	TCC	786	788	TCC	248;245;244	T;C,A;C,A	248;244,1;243,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6418	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3800	210.6	1	SNP	p	D95G	0	.	.	283	285	GAC	798	800	GAC	235;239;240	G;A,G;C,A	235;238,1;238,2	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6418	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3800	210.6	1	SNP	p	D95N	0	.	.	283	285	GAC	798	800	GAC	235;239;240	G;A,G;C,A	235;238,1;238,2	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	2342	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1876	155.8	1	SNP	p	G45D	1	.	.	133	135	GAC	750	752	GAC	274;274;274	G,A;A;C	273,1;274;274	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1332	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1366	121.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6104	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3399	223.7	1	SNP	p	D86N	0	.	.	256	258	GAC	785	787	GAC	283;281;279	G;A;C	283;281;279	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6104	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3399	223.7	1	SNP	p	S87W	0	.	.	259	261	AGT	788	790	AGT	276;279;282	A;G;T,G	276;279;281,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6104	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3399	223.7	1	SNP	p	S87I	0	.	.	259	261	AGT	788	790	AGT	276;279;282	A;G;T,G	276;279;281,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6104	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3399	223.7	1	SNP	p	S87R	0	.	.	259	261	AGT	788	790	AGT	276;279;282	A;G;T,G	276;279;281,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6104	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3399	223.7	1	SNP	p	S88P	0	.	.	262	264	TCC	791	793	TCC	279;280;282	T,C;C;C	278,1;280;282	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5326	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3159	210.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1874	1876	GGC	301;300;301	G,A;G;C,T,A	300,1;300;299,1,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1526	1528	GCA	296;295;292	G,A;C,T;A	293,3;294,1;292	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1529	1531	ATC	290;291;293	A,T;T;C	289,1;291;293	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1541	1543	GTG	286;285;286	G;T,G,A;G	286;283,1,1;286	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1541	1543	GTG	286;285;286	G;T,G,A;G	286;283,1,1;286	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2045	2047	ACC	258;260;262	A,T,C;C;C,G	256,1,1;260;261,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2099	2101	GCG	241;241;243	G,T;C,A;G	240,1;240,1;243	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2099	2101	GCG	241;241;243	G,T;C,A;G	240,1;240,1;243	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2222	2224	GGC	249;248;253	G,T;G,T;C,A	247,1;246,1;252,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2231	2233	GGC	255;253;254	G;G,T;C,T	255;252,1;253,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4696	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2900	201.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2249	2251	CCG	238;238;239	C,G;C;G	237,1;238;239	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6596	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3617	227.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1857	1859	CTG	275;277;276	C,A;T;G,T	274,1;277;275,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3166	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2260	174.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	767	767	C	231	C	231	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	629	631	GGA	272;279;281	G;G;A	272;279;281	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	V75I	NONSYN	223	225	GTT	710	712	ATT	288;287;287	A;T;T	288;287;287	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	T89S	NONSYN	265	267	ACC	752	754	AGC	261;259;261	A,G;G;C	260,1;259;261	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	V98I	NONSYN	292	294	GTC	779	781	ATC	237;236;233	A,T;T;C	236,1;236;233	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	.	MULTIPLE	358	359	AA	844	845	CG	224;225	C;G	224;225	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	.	MULTIPLE	361	362	GA	847	849	CAG	226;229;232	C;A;G	226;229;232	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	851	853	AAA	233;233;230	A;A;A,C	233;233;229,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	878	880	TAT	253;251;253	T;A;T,C	253;251;252,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	N134E	NONSYN	400	402	AAT	887	889	GAG	256;258;257	G;A;G,T	256;258;255,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	V135L	NONSYN	403	405	GTG	890	892	CTT	256;258;260	C,A;T,A;T	255,1;257,1;260	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	G140K	NONSYN	418	420	GGA	905	907	AAA	257;259;259	A,G;A;A	256,1;259;259	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	K143E	NONSYN	427	429	AAA	914	916	GAA	265;265;262	G,C,A;A;A	263,1,1;265;262	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	938	940	GCA	274;271;270	G;C;A	274;271;270	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1124	1126	TCA	306;304;302	T,A,G;C;A	303,2,1;304;302	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1244	1246	CAA	225;222;220	C;A,C;A	224;220,1;219	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	.	INDELS	760	761	AC	1248	1251	ATCG	219;214;211;212	A;T,A;C,A,T;G,T	218;213,1;208,2,1;211,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	.	INDELS	763	764	TG	1254	1257	TAGT	208;209;210;213	T;A;G;T	208;209;210;213	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1262	1264	GAT	217;215;215	G;A,G;T	216;214,1;215	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1370	1372	AGT	277;282;284	A;G,T;T	277;281,1;284	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1376	1378	GAC	288;288;288	G;A;C	288;288;288	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1379	1381	TAC	288;285;285	T;A;C	288;285;285	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	1	SNP	p	G120K	1	.	.	358	360	AAG	844	846	CGG	224;225;226	C;G;G,A,T	224;225;224,1,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	1	SNP	p	D121N	0	.	.	361	363	GAC	847	850	CGC	226;232;231	C;G;C	226;232;231	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3138	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1785	218.2	1	SNP	p	A121D	1	.	.	361	363	GAC	847	850	CGC	226;232;231	C;G;C	226;232;231	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	318	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	73.2	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	96;96;96	A;C;T	96;96;96	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	318	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	73.2	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	96;96;96	A;G,T;T	96;95,1;96	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	318	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	73.2	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	96;96;96	G;A;C	96;96;96	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	318	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	73.2	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	96;96;96	T;A;C	96;96;96	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11598	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5307	272.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2253	2255	AAT	319;315;313	A;A,C;T,G,A	319;314,1;311,1,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1618	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1410	142.8	1	SNP	p	V57M	1	.	.	169	171	ATG	721	723	ATG	300;299;299	A;T;G	300;299;299	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
